CN Bio and Pharmaron Establish Long-Term Strategic Partnership to Develop OOC Technologies on a Global R&D Platform

CN Bio and Pharmaron Establish Long-Term Strategic Partnership to Develop OOC Technologies on a Global R&D Platform

CAMBRIDGE, England--(BUSINESS WIRE)--Apr 23, 2025-

CN Bio and Pharmaron establish long-term partnership

CN Bio, a provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, has announced the establishment of a strategic partnership with Pharmaron, a premier R&D service provider for the industry.

CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform

Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development Cambridge, UK, 24 April 2025: CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, today announced the establishment of a strategic partnership with Pharmaron, a premier R&D service provider for the life sciences indus…